CATX - Perspective Therapeutics, Inc.

QQQ $ 441.71 $ 1.04 (0.24 %)

DIA $ 395.04 $ 1.18 (0.3 %)

SPY $ 520.76 $ 0.67 (0.13 %)

TLT $ 90.14 $ -0.51 (-0.56 %)

GLD $ 218.73 $ 1.76 (0.81 %)

Previous Close

$ 1.75

Open

$ 1.77

Bid

$ 1.74 x 3,200

Ask

$ 1.76 x 100

Day's Range

$ 1.66 - $ 1.77

52 Week Range

$ 0.21 - $ 1.90

Volume

4,905,770

Average Volume

Market Cap

1.03B

Beta (5Y Monthly)

$ 0.69

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	03-28-2024	12-31-2023	10-K
2	11-14-2023	09-30-2023	10-Q
3	08-11-2023	06-30-2023	10-Q
4	05-15-2023	03-31-2023	10-Q
5	11-14-2022	09-30-2022	10-Q
6	09-28-2022	06-30-2022	10-K
7	05-12-2022	03-31-2022	10-Q
8	02-09-2022	12-31-2021	10-Q
9	11-10-2021	09-30-2021	10-Q
10	09-27-2021	06-30-2021	10-K
11	05-14-2021	03-31-2021	10-Q
12	02-09-2021	12-31-2020	10-Q
13	11-13-2020	09-30-2020	10-Q
14	09-25-2020	06-30-2020	10-K
15	05-13-2020	03-31-2020	10-Q
16	02-12-2020	12-31-2019	10-Q
17	11-13-2019	09-30-2019	10-Q
18	09-27-2019	06-30-2019	10-K
19	05-10-2019	03-31-2019	10-Q
20	02-13-2019	12-31-2018	10-Q
21	11-09-2018	09-30-2018	10-Q
22	09-26-2018	06-30-2018	10-K
23	05-04-2018	03-31-2018	10-Q
24	02-09-2018	12-31-2017	10-Q
25	11-14-2017	09-30-2017	10-Q
26	09-28-2017	06-30-2017	10-K
27	05-10-2017	03-31-2017	10-Q
28	02-09-2017	12-31-2016	10-Q
29	11-09-2016	09-30-2016	10-Q
30	09-09-2016	06-30-2016	10-K
31	05-10-2016	03-31-2016	10-Q
32	02-09-2016	12-31-2015	10-Q
33	11-09-2015	09-30-2015	10-Q
34	09-14-2015	06-30-2015	10-K
35	05-15-2015	03-31-2015	10-Q
36	02-17-2015	12-31-2014	10-Q
37	11-14-2014	09-30-2014	10-Q
38	09-29-2014	06-30-2014	10-K
39	05-15-2014	03-31-2014	10-Q
40	02-14-2014	12-31-2013	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

Cantor Fitzgerald Initiates Coverage On Pe...
05/09/2024 10:22:12

Cantor Fitzgerald analyst Louis Chen initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Overweight rating.

FDA Selects Perspective Therapeutics To Pa...
04/30/2024 11:20:47

B. Riley Securities Maintains Buy on Persp...
04/09/2024 17:47:01

B. Riley Securities analyst Yuan Zhi maintains Perspective Therapeutics (AMEX:CATX) with a Buy and raises the price target f...

Oppenheimer Reiterates Outperform on Persp...
04/01/2024 13:27:02

Oppenheimer analyst Jeff Jones reiterates Perspective Therapeutics (AMEX:CATX) with a Outperform and raises the price target...

stocks-pause-as-traders-reassess-interest-rate-path-gold-makes-new-highs-bitcoin-rebounds-whats-driving-markets-thursday

Stocks Pause As Traders Reassess Interest ...
03/28/2024 17:49:57

In the final session of the short trading week leading up to Easter festivities, U.S. equity indices held steady, reflecting so...

Perspective Therapeutics FY2023 EPS $(0.14...
03/28/2024 11:35:34

Perspective Therapeutics (AMEX:CATX) reported quarterly losses of $(0.14) per share. This is a 133.33 percent decrease over los...

Oppenheimer Reiterates Outperform on Persp...
03/19/2024 13:02:16

Oppenheimer analyst Jeff Jones reiterates Perspective Therapeutics (AMEX:CATX) with a Outperform and maintains $1.2 price ta...

Perspective Therapeutics Announces Collabo...
03/18/2024 12:06:16

Perspective Therapeutics Acquires CGMP-Com...
03/05/2024 13:12:16

Perspective Therapeutics, Inc. ("Perspective" or "the Company") (NYSE:CATX), a radiopharmaceutical company that...

Perspective Therapeutics Shares Resume Trade
03/04/2024 15:00:34

Perspective Therapeutics Announces $87.4M ...
03/04/2024 14:46:14

Perspective Therapeutics, Inc. ("Perspective" or "the Company") (NYSE:CATX), a radiopharmaceutical company that...

Perspective Therapeutics Shares Halted, Ne...
03/04/2024 14:34:27

12-health-care-stocks-moving-in-thursdays-after-market-session

12 Health Care Stocks Moving In Thursday's...
02/15/2024 21:31:05

12-health-care-stocks-moving-in-fridays-after-market-session

12 Health Care Stocks Moving In Friday's A...
02/09/2024 21:31:09

12-health-care-stocks-moving-in-wednesdays-intraday-session

12 Health Care Stocks Moving In Wednesday'...
02/07/2024 17:31:16

expensify-and-3-other-stocks-under-3-insiders-are-buying

Expensify And 3 Other Stocks Under $3 Insi...
02/02/2024 12:09:11

The Dow Jones index closed higher by more than 350 points on Thursday. When insiders purchase or sell shares, it indicates thei...

Perspective Therapeutics Signs License Agr...
02/01/2024 13:15:18

Signs a World-Wide Exclusive License with Stony Brook University for a Novel Platform that can Enhance Radionuclide Targeting R...

expensify-and-2-other-stocks-under-2-insiders-are-buying

Expensify And 2 Other Stocks Under $2 Insi...
01/31/2024 11:30:59

The Dow Jones index closed higher by more than 100 points on Tuesday. When insiders purchase or sell shares, it indicates their...

perspective-therapeutics-and-3-other-stocks-under-2-insiders-are-buying

Perspective Therapeutics And 3 Other Stock...
01/29/2024 13:53:33

The Dow Jones index closed higher by around 60 points on Friday. When insiders purchase or sell shares, it indicates their conf...

B. Riley Securities Initiates Coverage On ...
01/26/2024 16:39:07

B. Riley Securities analyst Yuan Zhi initiates coverage on Perspective Therapeutics (AMEX:CATX) with a Buy rating and announ...